Case study · Medical devices and diagnostics

£5m+ public-sector award for clinical diagnostic technology supply

The client was selected by Department of Health and Social Care programme to provide clinical diagnostic technology supply. The contract carried a £5m+ value marker.

Editorial delivery context for £5m+ public-sector award for clinical diagnostic technology supply
Medical devices and diagnostics
Contract
Public
Buyer
Department of Health and Social Care programme
Contract value
£5m+
Result
Contract award secured
Route
Framework call-off

Client confidentiality Client identity and sensitive details are withheld; project facts are generalised only where needed to keep the case useful without identifying protected parties.

Before

The pursuit problem

The pursuit had to make clinical diagnostic technology supply credible against close buyer scrutiny of reagent/platform lock-in, uptime, calibration and lifecycle cost.

Bid Champions’ role

What changed

Bid Champions’ team supported the agreed tender workstream through to submission.

After

The result

Contract award secured. Contract value: £5m+. The client retained a reusable public-sector reference for validated diagnostic technology and clinical support.

Work carried out by Bid Champions

The work behind this £5m+ medical devices and diagnostics pursuit.

The pursuit moved through five connected stages, with each decision tied to a practical output and the final submission.

Decision to unlock

The response had to prove reagent/platform lock-in, uptime, calibration and lifecycle cost.

  1. 01

    Control decomposition

    Turned requirements into testable controls

    Separated every mandatory standard, risk, safeguard and reporting obligation, including implied tests hidden in method questions.

    Project output A compliance and control matrix with no orphan requirements.

  2. 02

    Evidence tracing

    Attached proof before drafting the claim

    Identified the current policy, record, accreditation, competence evidence or operating example that can support it for each control.

    Project output A claim-source-owner-date evidence register.

  3. 03

    Scenario writing

    Showed the control operating under pressure

    Wrote the normal method, exception path, escalation, decision authority and recovery action in evaluator-readable sequence.

    Project output Operational answers that demonstrate control in realistic scenarios.

  4. 04

    Assurance threading

    Connected governance to frontline delivery

    Showed how oversight, audit, reporting and corrective action test whether the promised control remains effective.

    Project output A joined operational and governance narrative.

  5. 05

    Independent challenge

    Red-teamed the material claims

    Challenged unsupported absolutes, expired proof, unclear ownership and gaps between policy wording and actual delivery.

    Project output A release-ready response with a closed evidence-gap log.

Project control spineRequirement → control → named owner → current evidence → independent challenge

Why it mattered

The response becomes auditable and easier to score because assurance is embedded in the operating answer rather than left in policies or appendices.

Inside the buyer decision

Four shifts in the buyer’s risk picture.

Each card follows the same route: the risk, the work completed, the proof created and the effect on the decision.

  1. 01

    Buyer decision

    Turned requirements into testable controls

    01 · The risk
    The pursuit had to make clinical diagnostic technology supply credible against close buyer scrutiny of reagent/platform lock-in, uptime, calibration and lifecycle cost.
    02 · Work completed
    Separated every mandatory standard, risk, safeguard and reporting obligation, including implied tests hidden in method questions.
    03 · Proof created
    A compliance and control matrix with no orphan requirements.
    Outcome · Decision effect
    A compliance and control matrix with no orphan requirements gave Department of Health and Social Care programme a concrete basis for judging buyer decision.
  2. 02

    Operating reality

    Attached proof before drafting the claim

    01 · The risk
    The response had to prove reagent/platform lock-in, uptime, calibration and lifecycle cost.
    02 · Work completed
    Identified the current policy, record, accreditation, competence evidence or operating example that can support it for each control.
    03 · Proof created
    A claim-source-owner-date evidence register.
    Outcome · Decision effect
    Department of Health and Social Care programme could test operating reality against a claim-source-owner-date evidence register rather than relying on an unsupported claim.
  3. 03

    Commercial pressure

    Showed the control operating under pressure

    01 · The risk
    The Department of Health and Social Care programme decision brought solution, price, operational evidence, capacity and contractual commitments into one award decision.
    02 · Work completed
    Wrote the normal method, exception path, escalation, decision authority and recovery action in evaluator-readable sequence.
    03 · Proof created
    Operational answers that demonstrate control in realistic scenarios.
    Outcome · Decision effect
    Operational answers that demonstrate control in realistic scenarios made commercial pressure visible and reviewable for Department of Health and Social Care programme.
  4. 04

    Stakeholder fit

    Connected governance to frontline delivery

    01 · The risk
    The medical devices and diagnostics proposition had to hold together from requirement → control → named owner → current evidence → independent challenge.
    02 · Work completed
    Showed how oversight, audit, reporting and corrective action test whether the promised control remains effective.
    03 · Proof created
    A joined operational and governance narrative.
    Outcome · Decision effect
    The submission connected stakeholder fit to a joined operational and governance narrative so Department of Health and Social Care programme did not have to infer how it would work.

Professional controls applied to the problem

Professional practice and relevant key drivers.

These examples are tied to the work and outputs above, within the wider assurance approach used across the project.

APMP practices used on this project

These three APMP proposal-management practices shaped the requirement, evidence and release work for £5m+ public-sector award for clinical diagnostic technology supply.

  1. 01

    RFP review

    Separated every mandatory standard, risk, safeguard and reporting obligation, including implied tests hidden in method questions. A compliance and control matrix with no orphan requirements.

  2. 02

    Compliance matrix

    Identified the current policy, record, accreditation, competence evidence or operating example that can support it for each control. A claim-source-owner-date evidence register.

  3. 03

    Pink / Red / Gold reviews

    Challenged unsupported absolutes, expired proof, unclear ownership and gaps between policy wording and actual delivery. A release-ready response with a closed evidence-gap log.

Relevant key drivers for this pursuit

These are three relevant examples from the broader project assurance—not the full set of controls applied.

  1. 01

    ISO 9001 · Quality management

    For this £5m+ medical devices and diagnostics pursuit, a key driver was requirement ownership, evidence traceability, staged review and release control. It governed A claim-source-owner-date evidence register and directly addressed reagent/platform lock-in, uptime, calibration and lifecycle cost.

  2. 02

    ISO/IEC 27001 · Information security

    For this £5m+ medical devices and diagnostics pursuit, a key driver was information ownership, secure handling, access, supplier dependencies and incident response. It governed A compliance and control matrix with no orphan requirements and directly addressed reagent/platform lock-in, uptime, calibration and lifecycle cost.

  3. 03

    ISO 31000 · Risk management

    For this £5m+ medical devices and diagnostics pursuit, a key driver was risk identification, owned mitigations, dependencies and decision-stage review. It governed A joined operational and governance narrative and directly addressed reagent/platform lock-in, uptime, calibration and lifecycle cost.

Control sequenceShape → Renew

This sequence connected the buyer’s concern to owned work, reviewable evidence and the final release decision.

Why the bid won

The response made the delivery decision easier.

The response becomes auditable and easier to score because assurance is embedded in the operating answer rather than left in policies or appendices.

The response built buyer confidence around validated diagnostic technology, clinical support, maintenance capability and deployment readiness. The winning pattern was a compliant and commercially acceptable response that converted those capabilities into a credible mobilisation and delivery case, reducing perceived execution risk.

Result
Contract award secured
Contract value
£5m+

What remained after submission

Capability the client could use again.

The client retained a reusable public-sector reference for validated diagnostic technology and clinical support.

Decision room · Medical devices and diagnostics · 3 decisions · About 60 seconds

Take the decisions behind this £5m+ medical devices and diagnostics pursuit

Solve three connected pieces of the pursuit. Choose a route, then reveal what happened on this project.

The starting position

The pursuit had to make clinical diagnostic technology supply credible against close buyer scrutiny of reagent/platform lock-in, uptime, calibration and lifecycle cost.

Decision 1 of 3

Decision 01

The buyer had to resolve control decomposition. What happened first?

Decision 02

With £5m+ at stake, which move made evidence tracing credible?

Decision 03

What created a defensible release decision for this medical devices and diagnostics response?

Facing a similar constraint?

Give Bid Champions the target. Keep the approvals. Hand over the pursuit work.

We can test the buyer route, strengthen the bidder and offer, build the evidence and commercial case, write the response and control it through submission.